305 related articles for article (PubMed ID: 12485451)
21. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
Bouillon R; Allewaert K; Xiang DZ; Tan BK; van Baelen H
J Bone Miner Res; 1991 Oct; 6(10):1051-7. PubMed ID: 1796753
[TBL] [Abstract][Full Text] [Related]
22. 1,25-Dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K/Akt/mTOR signaling cascade.
Datta-Mitra A; Mitra A; Ray R; Raychaudhuri SP; Kundu-Raychaudhuri S
Int Immunopharmacol; 2013 Nov; 17(3):744-51. PubMed ID: 24036370
[TBL] [Abstract][Full Text] [Related]
23. 2-Methylene analogs of 1alpha-hydroxy-19-norvitamin D3: synthesis, biological activities and docking to the ligand binding domain of the rat vitamin D receptor.
Grzywacz P; Plum LA; Sicinska W; Sicinski RR; Prahl JM; DeLuca HF
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):13-7. PubMed ID: 15225739
[TBL] [Abstract][Full Text] [Related]
24. Effects of novel 26,27-dialkyl analogs of 1 alpha,25-dihydroxyvitamin D3 on differentiation-inducing activity of human promyelocytic leukemia (HL-60) cells in serum-supplemented or serum-free culture.
Honda A; Mori Y; Otomo S; Ishizuka S; Ikekawa N
Steroids; 1991 Mar; 56(3):142-7. PubMed ID: 1645892
[TBL] [Abstract][Full Text] [Related]
25. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns.
Sadeghi K; Wessner B; Laggner U; Ploder M; Tamandl D; Friedl J; Zügel U; Steinmeyer A; Pollak A; Roth E; Boltz-Nitulescu G; Spittler A
Eur J Immunol; 2006 Feb; 36(2):361-70. PubMed ID: 16402404
[TBL] [Abstract][Full Text] [Related]
27. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA
J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
[TBL] [Abstract][Full Text] [Related]
28. Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential.
Cross HS; Farsoudi KH; Peterlik M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):105-10. PubMed ID: 8446178
[TBL] [Abstract][Full Text] [Related]
29. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
[TBL] [Abstract][Full Text] [Related]
30. A synthetic analogue of vitamin D3, 22-oxa-1 alpha,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice.
Abe J; Takita Y; Nakano T; Miyaura C; Suda T; Nishii Y
Endocrinology; 1989 May; 124(5):2645-7. PubMed ID: 2539984
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
[TBL] [Abstract][Full Text] [Related]
32. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
[TBL] [Abstract][Full Text] [Related]
33. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
Daniel C; Radeke HH; Sartory NA; Zahn N; Zuegel U; Steinmeyer A; Stein J
J Pharmacol Exp Ther; 2006 Nov; 319(2):622-31. PubMed ID: 16914561
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological activity of 22-iodo- and (E)-20(22)-dehydro analogues of 1alpha,25-dihydroxyvitamin D3.
Sicinski RR; DeLuca HF
Bioorg Med Chem; 1999 Dec; 7(12):2877-89. PubMed ID: 10658592
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes.
Clavreul A; D'hellencourt CL; Montero-Menei C; Potron G; Couez D
Immunology; 1998 Oct; 95(2):272-7. PubMed ID: 9824486
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
37. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
38. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
39. Growth inhibition and differentiation in HL-60 leukemia cells induced by 1,25-dihydroxyvitamin D3 and tumor necrosis factor alpha.
Wang SY; Chen LY; Wang SJ; Lin CK; Ho CK
Exp Hematol; 1991 Nov; 19(10):1025-30. PubMed ID: 1915703
[TBL] [Abstract][Full Text] [Related]
40. Decreased accessory cell function and costimulatory activity by 1,25-dihydroxyvitamin D3-treated monocytes.
Rigby WF; Waugh MG
Arthritis Rheum; 1992 Jan; 35(1):110-9. PubMed ID: 1370618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]